Black Rock Inc. Prothena Corp Public LTD CO Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PRTA
# of Institutions
219Shares Held
35MCall Options Held
656KPut Options Held
1.12M-
Vanguard Group Inc Valley Forge, PA2.05MShares$21 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY1.82MShares$18.7 Million0.27% of portfolio
-
Rubric Capital Management LP New York, NY1.54MShares$15.8 Million0.25% of portfolio
-
Adar1 Capital Management, LLC Austin, TX1.47MShares$15.1 Million1.35% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.32MShares$13.6 Million2.57% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $481M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...